Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 4
1987 1
1989 1
1990 1
1994 1
1995 1
1996 2
1998 1
2009 1
2011 1
2012 1
2013 2
2014 2
2015 3
2016 2
2017 3
2018 2
2019 1
2021 1
2022 2
2023 1
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Schilsky ML, Czlonkowska A, Zuin M, Cassiman D, Twardowschy C, Poujois A, Gondim FAA, Denk G, Cury RG, Ott P, Moore J, Ala A, D'Inca R, Couchonnal-Bedoya E, D'Hollander K, Dubois N, Kamlin COF, Weiss KH; CHELATE trial investigators. Schilsky ML, et al. Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1092-1102. doi: 10.1016/S2468-1253(22)00270-9. Epub 2022 Sep 30. Lancet Gastroenterol Hepatol. 2022. PMID: 36183738 Clinical Trial.
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta.
Degasperi E, Scholtes C, Testoni B, Renteria SU, Anolli MP, Charre C, Facchetti F, Plissonnier ML, Sambarino D, Perbellini R, Monico S, Callegaro A, García-Pras E, Lens S, Cortese MF, Forns X, Pérez-Del-Pulgar S, Heil M, Levrero M, Zoulim F, Lampertico P. Degasperi E, et al. Among authors: monico s. J Hepatol. 2025 Jun;82(6):1004-1011. doi: 10.1016/j.jhep.2024.11.051. Epub 2024 Dec 9. J Hepatol. 2025. PMID: 39662705
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B.
Kalafateli M, Forlano R, Barnes E, Martinez-Gili L, Lacey M, Sigon G, Mullish BH, Mallet V, Parlati L, Richardson P, Forde N, Serviddio G, Villani R, Lens S, Buti M, Vargas E, Viganò M, Loglio A, Lampertico P, D'ambrosio R, Monico S, Maffi G, Lombardi R, Fracanzani AL, De Luca C, Ingiliz P, Mangia A, Leserre F, Napolitano AM, Piazzolla V, Russo FP, Raimondo G, Cacciola I, Saitta C, Lemoine M, Papatheodoridis G, Papatheodoridi M, Samonakis DN, O'Donnell D, O'Donoghue J, Abeles RD, Pugliese N, Aghemo A, Berenguer M, Brown A, Thursz MR, Manousou P. Kalafateli M, et al. Among authors: monico s. Clin Gastroenterol Hepatol. 2025 Jul 2:S1542-3565(25)00533-6. doi: 10.1016/j.cgh.2025.06.014. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40609817 Free article.
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA.
Caviglia GP, Fariselli P, D'Ambrosio R, Colombatto P, Degasperi E, Ricco G, Abate ML, Birolo G, Troshina G, Damone F, Coco B, Cavallone D, Perbellini R, Monico S, Saracco GM, Brunetto MR, Lampertico P, Ciancio A. Caviglia GP, et al. Among authors: monico s. Aliment Pharmacol Ther. 2025 Feb;61(3):538-549. doi: 10.1111/apt.18409. Epub 2024 Nov 21. Aliment Pharmacol Ther. 2025. PMID: 39569574 Free PMC article.
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years.
Farina E, Loglio A, Tosetti G, Degasperi E, Viganò M, Gentile C, Monico S, Perbellini R, Borghi M, Facchetti F, Uceda Renteria SC, Ceriotti F, Cerini F, Primignani M, Lampertico P. Farina E, et al. Among authors: monico s. Aliment Pharmacol Ther. 2023 Jun;57(12):1407-1416. doi: 10.1111/apt.17463. Epub 2023 Mar 28. Aliment Pharmacol Ther. 2023. PMID: 36978230
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension.
Degasperi E, Anolli MP, Uceda Renteria SC, Sambarino D, Borghi M, Perbellini R, Scholtes C, Facchetti F, Loglio A, Monico S, Fraquelli M, Costantino A, Ceriotti F, Zoulim F, Lampertico P. Degasperi E, et al. Among authors: monico s. J Hepatol. 2022 Dec;77(6):1525-1531. doi: 10.1016/j.jhep.2022.07.016. Epub 2022 Aug 13. J Hepatol. 2022. PMID: 35973578
35 results